Wells Fargo & Company Verastem, Inc. Transaction History

Wells Fargo & Company

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 12, 2023	BUY	$0.39 - $0.71 $3,103 - $5,649	7,957 Added 60.39%	21,133 $8,000
Q4 2022 Feb 13, 2023	SELL	$0.33 - $10.44 $24,194 - $765,419	-73,316 Reduced 84.77%	13,176 $5,000
Q3 2022 Nov 14, 2022	BUY	$0.92 - $11.16 $11,885 - $144,176	12,919 Added 17.56%	86,492 $73,000
Q2 2022 Aug 12, 2022	SELL	$1.02 - $1.83 $414,043 - $742,842	-405,925 Reduced 84.66%	73,573 $85,000
Q1 2022 May 16, 2022	SELL	$1.06 - $2.1 $33,390 - $66,150	-31,500 Reduced 6.16%	479,498 $677,000
Q4 2021 Feb 14, 2022	BUY	$2.05 - $3.2 $285,636 - $445,872	139,335 Added 37.49%	510,998 $1.05 Million
Q3 2021 Nov 15, 2021	BUY	$2.54 - $4.07 $788,847 - $1.26 Million	310,570 Added 508.36%	371,663 $1.14 Million
Q2 2021 Aug 16, 2021	SELL	$2.57 - $4.85 $342,347 - $646,063	-133,209 Reduced 68.56%	61,093 $249,000
Q1 2021 May 13, 2021	SELL	$1.9 - $2.82 $196,000 - $290,905	-103,158 Reduced 34.68%	194,302 $481,000
Q4 2020 Feb 09, 2021	SELL	$1.15 - $2.4 $57,648 - $120,309	-50,129 Reduced 14.42%	297,460 $634,000
Q3 2020 Nov 05, 2020	BUY	$1.11 - $1.68 $28,339 - $42,892	25,531 Added 7.93%	347,589 $420,000
Q2 2020 Aug 13, 2020	BUY	$1.69 - $4.2 $530,332 - $1.32 Million	313,806 Added 3802.79%	322,058 $554,000
Q1 2020 May 14, 2020	BUY	$1.26 - $3.38 $10,397 - $27,891	8,252 New	8,252 $22,000

297K

Ticker VSTM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 210,000,000
Market Cap $1.09B
Description
Verastem, Inc., a development-stage biopharmaceutical company, focusing on developing and commercializing drugs for the treatment of cancer. Its product in development includes VS-6766, a dual rapidly accelerated fibrosarcoma (RAF)/mitogen-activated protein kinase (MEK) clamp that blocks MEK kinase activity and the ability of RAF to phosphorylat...

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

Stay updated on Wells Fargo & Company with notifications on news.